DIACABS vs URJA: Stock Comparison

DIACABS vs URJA GLOBALUpdated 3 Aug 26, 4:08 PM ISTNSE & company filings

DIACABS is the larger company by market capitalisation. DIACABS shows a lower P/E, faster revenue growth and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

DIACABS leads 9; URJA leads 1 of 11

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

DIACABSURJA

Valuation lens

What price are you paying?

Market CapContext only
₹19,385 Cr
₹510 Cr
P/E RatioDIACABS has the lower reading
98.62x
315.67x
P/B RatioDIACABS has the lower reading
-32.07x
2.99x
EPSDIACABS has the higher reading
₹1.11
₹0.01
Book ValueContext only
₹3.43
Dividend YieldSame reading
0%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
DIACABS is the larger company
₹19,385 Cr vs ₹510 Cr
P/E Ratio
DIACABS has a lower P/E
98.62x vs 315.67x
P/B Ratio
DIACABS has a lower P/B
-32.07x vs 2.99x
EPS
DIACABS has higher earnings per share
₹1.11 vs ₹0.01
Revenue Growth (TTM YoY)
DIACABS has faster revenue growth
108.5% vs 2.3%
EPS Growth (TTM YoY)
DIACABS has faster EPS growth
691.9% vs 0%
Qtr Sales Growth
URJA has stronger quarterly sales growth
5.11% vs -2.46%
Qtr Profit Growth
DIACABS has stronger quarterly profit growth
2.38% vs -30.29%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricDIACABSURJA
SectorCapital GoodsCapital Goods
IndustryOther Electrical EquipmentOther Electrical Equipment

Price

MetricDIACABSURJA
Live Price₹322.85₹9.15
Day Change-0.35%0.55%
Volume31.41 L5.38 L
52-Week High₹342₹14.45
52-Week Low₹115.57₹8
Distance from 52W High-5.6%-36.68%

Valuation

MetricDIACABSURJA
Market Cap₹19,385 Cr₹510 Cr
P/E Ratio98.62x315.67x
P/B Ratio-32.07x2.99x
EPS₹1.11₹0.01
Book Value₹3.43
Dividend Yield0%0%

Growth

MetricDIACABSURJA
Revenue Growth (TTM YoY)108.5%2.3%
EPS Growth (TTM YoY)691.9%0%
Qtr Sales Growth-2.46%5.11%
Qtr Profit Growth2.38%-30.29%

Profitability & Leverage

MetricDIACABSURJA
ROE1.02%
ROCE9.55%1.02%
Net Margin8.28%1.74%
Operating Margin8.89%4.37%
Debt to Equity0x

Shareholding

As of Jul 2026 • change vs previous quarter
MetricDIACABSURJA
Promoter Holding74.03% 9.99 pp17.37% 0.98 pp
FII Holding4.57% 2.81 pp0.02% 0.08 pp
DII Holding10.95% 10.71 pp0%
Public Holding10.45% 3.53 pp82.61% 1.07 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: DIACABS and URJA GLOBAL.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.